Professor of Medicine
Divisions of Infectious Diseases and Hepatology/Gastroenterology
Department of Medicine
The Johns Hopkins University School of Medicine
- Clinical issues in the management of hepatitis C virus and HIV coinfection
Dr Sulkowski is a Professor of Medicine at the Johns Hopkins University School of Medicine, and the Medical Director of the Johns Hopkins University Center for Viral Hepatitis, Division of Infectious Diseases. He teaches students and fellows at the Infectious Diseases Consult Service and Viral Hepatitis Clinic.
- Associate Member, American College of Physicians (1992–1995)
- American Medical Association (1993–1995)
- Member, Infectious Diseases Society of America (1995–present)
- Vice-President and Director of Clinical Research, Hepatitis Resource Network (1998–present)
- Member, American Association for the Study of Liver Diseases (2001)
- National Merit Scholarship, Lehigh University (1984)
- Phi Beta Kappa, Summa Cum Laude Graduate, Lehigh University (1988)
- Alpha Omega Alpha (1991)
- Emanuel M. Weinberger Award for Achievement in Infectious Diseases, Temple University School of Medicine (1992)
- Junior Faculty Award for Patient-Directed Research in Infectious Disease, SmithKline Beecham Pharmaceuticals (2000)
- Lehigh University, BS, Biology (1988)
- Temple University School of Medicine, MD (1992)
- Duke University Medical Center, Internship in Medicine (1992–1993)
- Duke University Medical Center, Residency in Medicine (1993–1995)
- The Johns Hopkins University School of Medicine, Fellowship in Infectious Diseases (1995–1998)
- The Johns Hopkins University School of Hygiene and Public Health, Postdoctoral Studies in Biostatistics and Epidemiology (1996)
- Sulkowski MS, et al. Pegylated interferon α-2a (PEGASYS™) and ribavirin combination therapy for chronic hepatitis C: a phase II open-label study. Abstract at Dig Dis Week. May 2000; San Diego, Calif.
- Sulkowski MS, et al. Changes in hemoglobin during therapy with interferon alfa-2b plus ribavirin therapy in IFN-naive and experienced patients. Poster presentation at the 51st Annual Meeting of the American Association for the Study of Liver Diseases. Hepatology. 2000;32:368A. Abstract 834.
- Sulkowski MS, Dumler JS. The clinical spectrum of disease due to ehrlichia chaffeensis: case report and review. Infect Dis Clin Pract. 1998;7:252-256.
- Sulkowski MS. Hepatitis C virus and HIV co-infection: a sleeping giant wakes. The Hopkins HIV Report. 1999;11:3-12.
- Sulkowski MS, Chaisson RE, Karp CL, Margolick JB, Moore RD, Quinn TC. The effect of acute infections on plasma HIV-1 viral load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis. 1998;178:1642-1648.
- Sulkowski MS, Chaisson RE. Gastrointestinal manifestations of HIV infection. In: Mandell GE, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. New York, NY: Churchill-Livingstone; 1999.
- Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in HIV-infected adults: role of protease inhibitors and hepatitis C virus infection. JAMA. 2000;283:74-80.
- Sulkowski MS, Mast EE, Seef LB, Thomas DL. Hepatitis C virus infection as an opportunistic infection in HIV-infected persons. Clin Infect Dis. 2000;30:S77-S84.
- Mehta S, Brancati F, Sulkowski MS, Strathdee S, Szlko M, Thomas DL. Prevalence of type II diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133:592-599.
- Cummings KJ, Lee SM, West ES, Cid-Ruzafa J, Fein SG, Aoki Y, Sulkowski MS, Goodman SN. Interferon and ribavirin versus interferon alone in the retreatment of chronic hepatitis C non-responsive to previous interferon: a meta-analysis of randomized trials. JAMA. 2001;285:193-199.